Evaluation of Balance and Functionality in Postmenopausal Osteoporosis Using Quadriceps Femoris Muscle Thickness, Beyond Thoracic Hyperkyphosis
Evaluation of the Relationship Between Thoracic Kyphosis and Quadriceps Muscle Thickness with Balance and Fall Risk in Women with Postmenopausal Osteoporosis
1 other identifier
observational
103
1 country
2
Brief Summary
To determine the impact of thoracic hyperkyphosis, sarcopenia and quadriceps muscle thickness evaluated by ultrasonography (USG) on balance, fall risk and functional parameters in women with postmenopausal osteoporosis, to assess their interrelationships and to compare the clinical characteristics of sarcopenia and thoracic hyperkyphosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2023
CompletedFirst Submitted
Initial submission to the registry
December 27, 2024
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedJanuary 8, 2025
January 1, 2025
6 months
December 27, 2024
January 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
tandem stance and gait test
static and dynamic balance was measured.
Data were collected over a single measurement period of 6 months.
berg balance scale
Berg balance scale was originally developed for the assessment of postural control and is widely used in many areas of rehabilitation. There are 14 items in the scale, like commonly performing in daily activities sitting and standing balance, transfers, turning, and retrieving objects from the floor. The highest total score is 56 points. If the patient scores between 0-20 points, they are considered wheelchair dependent, between 21-40 points they can walk with assistance and between 41-56 points they are considered independent in mobilization activities.
Data were collected over a single measurement period of 6 months.
Timed up and go test
There is a significant relationship between TUG times and functional mobility level
Data were collected over a single measurement period of 6 months.
chair stand test
The five times CST evaluates the strength, power, and endurance of the lower extremity muscle group, particularly the quadriceps femoris muscle
Data were collected over a single measurement period of 6 months.
quadriceps femoris muscle thickness
evaluated by ultrasound
Data were collected over a single measurement period of 6 months.
thoracic kyphosis
The lateral thoracic vertebra radiographs were taken while standing position, the Cobb angle was automatically obtained by computer-aided method by marking the parallel lines drawn from the upper edge of the upper thoracic vertebra (T4), and the lower edge of the lower thoracic vertebra (T12)
Data were collected over a single measurement period of 6 months.
Eligibility Criteria
Patients aged 50 years and over with postmenopausal osteoporosis and/or osteoporotic vertebral fractures according to WHO criteria who applied to the outpatient clinic of the Department of Physical Medicine and Rehabilitation, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine
You may qualify if:
- Patient who were 50 years of age or older, had postmenopausal osteoporosis and/or osteoporotic vertebral fractures according to WHO criteria,
- Patient who were able to ambulate without any assistive devices
You may not qualify if:
- History of neurological disease which may affect balance and proprioception,
- Visual and vestibular disease
- Previous major lower extremity surgery or previous vertebra surgery
- Advanced heart, liver, or renal failure
- Stage 4 knee osteoarthritis
- Psychiatric disorders
- Use of any medication affecting the central nervous system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Istanbul University Cerrahpasa
Istanbul, Istanbul, 59030, Turkey (Türkiye)
Istanbul University Cerrahpasa, Cerrahpasa Medical Faculty
Istanbul, SÜLEYMANPAŞA, 59030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ESLEM PEKER BELENE
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
- STUDY DIRECTOR
ZEYNEP ÜLKÜ AKARIRMAK
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
- STUDY CHAIR
RANA TERLEMEZ
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
- STUDY CHAIR
OSMAN AYKAN KARGIN
Istanbul University- Cerrahpasa, Cerrahpasa Medical Faculty
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 7, 2025
Study Start
July 1, 2022
Primary Completion
December 31, 2022
Study Completion
November 29, 2023
Last Updated
January 8, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 12 months after publication of primary results
- Access Criteria
- Academic and Clinical Researchers, Regulatory Authorities and Non-commercial Researchers and Public Health Organizations can access the data Demographic and Clinical Data, Outcome Measures,Study protocols, statistical analysis plans, and publications can be accessed Submit a Request, Approval Process, Secure Access will be accessed
all IPD that underlie results in a publication